Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease
暂无分享,去创建一个
Dwight C. German | D. German | Kate Luby-Phelps | C. Liang | Chang-Lin Liang | Tom T. Wang | K. Luby‐Phelps
[1] D. German,et al. Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+) , 2006, Experimental Neurology.
[2] V. Chan‐Palay,et al. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression , 1989, The Journal of comparative neurology.
[3] Robert Hill,et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.
[4] Robert W. Taylor,et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.
[5] D. Nicholls,et al. Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. , 2002, The international journal of biochemistry & cell biology.
[6] L. Pozzo-Miller,et al. Correlated Calcium Uptake and Release by Mitochondria and Endoplasmic Reticulum of CA3 Hippocampal Dendrites after Afferent Synaptic Stimulation , 2002, The Journal of Neuroscience.
[7] S. Snyder,et al. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[8] Marjan S. Bolouri,et al. Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.
[9] D. German,et al. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter , 1998, Neuroscience.
[10] D. German,et al. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter‐2: Human midbrain dopamine neurons , 2004, The Journal of comparative neurology.
[11] Nicolas Lapointe,et al. Rotenone induces non‐specific central nervous system and systemic toxicity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] Jurgen Seidel,et al. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] M. Beal,et al. Bioenergetic and oxidative stress in neurodegenerative diseases. , 1995, Life sciences.
[14] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[15] N. Wood,et al. Expanding insights of mitochondrial dysfunction in Parkinson's disease , 2006, Nature Reviews Neuroscience.
[16] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[17] H. Yoshino,et al. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.
[18] P. Brundin,et al. Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line* , 2002, The Journal of Biological Chemistry.
[19] Anthony H V Schapira,et al. Etiology of Parkinson’s disease , 2006, Neurology.
[20] A. Szewczyk,et al. Mitochondria as a Pharmacological Target , 2002, Pharmacological Reviews.
[21] E. Masliah,et al. Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP 1 1 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 2004, Experimental Neurology.
[22] D. German,et al. Leucine5‐enkephalin afferents to midbrain dopaminergic neurons: Light and electron microscopic examination , 1993, The Journal of comparative neurology.
[23] Wade K. Smith,et al. Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.
[24] D. German,et al. Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease , 1991, Annals of neurology.
[25] D. German,et al. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[26] A. Torroni,et al. Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.
[27] C. Geula,et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons , 2006, Nature Genetics.
[28] J. C. Greene,et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] Diana Brahams,et al. Medicine and the Law , 1983, The Lancet.
[30] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[31] Tamas L. Horvath,et al. Uncoupling Protein-2 Is Critical for Nigral Dopamine Cell Survival in a Mouse Model of Parkinson's Disease , 2005, The Journal of Neuroscience.
[32] J. Langston,et al. Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.
[33] Wade K. Smith,et al. Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.
[34] D. Friel,et al. Depolarization-Induced Mitochondrial Ca Accumulation in Sympathetic Neurons: Spatial and Temporal Characteristics , 1999, The Journal of Neuroscience.
[35] Sunhong Kim,et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.
[36] B. A. Brooks,et al. Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a , 1992, Annals of the New York Academy of Sciences.
[37] D. German,et al. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[38] Reidun Torp,et al. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. , 2005, Human molecular genetics.
[39] J. Timothy Greenamyre,et al. [3H]Dihydrorotenone Binding to NADH: Ubiquinone Reductase (Complex I) of the Electron Transport Chain: An Autoradiographic Study , 1996, The Journal of Neuroscience.
[40] D. German,et al. Electrophysiological and pharmacological evidence for the existence of distinct subpopulations of nigrostriatal dopaminergic neuron in the rat , 1988, Neuroscience.
[41] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[42] W. Nicklas,et al. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.
[44] C. Winters,et al. Excitotoxic Calcium Overload in a Subpopulation of Mitochondria Triggers Delayed Death in Hippocampal Neurons , 2004, The Journal of Neuroscience.
[45] J. Parks,et al. High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging , 2004, Neurobiology of Aging.
[46] T. Weatherby,et al. Heterogeneity of the calcium‐induced permeability transition in isolated non‐synaptic brain mitochondria , 2002, Journal of neurochemistry.
[47] Jean Féger,et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats , 2003, Journal of neurochemistry.
[48] R. Swerdlow,et al. Mitochondrial dysfunction in idiopathic Parkinson disease. , 1998, American journal of human genetics.
[49] M. Yahr,et al. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease , 1994, Journal of neural transmission. Parkinson's disease and dementia section.
[50] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[51] P. Bywood,et al. Mitochondrial Complex Inhibitors Preferentially Damage Substantia Nigra Dopamine Neurons in Rat Brain Slices , 2003, Experimental Neurology.
[52] R. Swerdlow,et al. Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines , 2000, Experimental Neurology.
[53] J. Korf,et al. The Neurobiology of dopamine , 1979 .